FDA Inspection
Boston IVFBoston IVF – FDA Inspection, Apr 16, 2014
Record Details
This FDA Inspection record concerns Boston IVF, with an inspection on April 16, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Boston IVF
- Inspection Date
- April 16, 2014
- Product Type
- Biologics
View Company Profile
ID · a0c9e30a-5925-4fa0-98b2-a0939e70e924
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 875203
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Boston IVF
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 18, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 13, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Boston IVF
- FDA Inspection 1250882 - 2024-09-19
- FDA Inspection 1114951 - 2019-12-06
- FDA Inspection 1023194 - 2017-07-21
- FDA Inspection 753544 - 2011-11-18
- FDA Inspection 680986 - 2010-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.